Monitor the first quarterly report from Vylor (SpinCo) to assess the financial profile of the seed business and the financial impact of the separation. The supply agreement with Corteva provides visibility into Vylor's seed treatment costs and purchase obligations.
Price Chart
Executive Summary
Corteva (CTVA) has completed the separation of its seed seed business into a new publicly traded company, Vylor Inc., effective October 1, 2026. Corteva will retain its crop protection business (RemainCo) and distribute all Vylor shares to Corteva stockholders on a 1:1 basis. The separation is accompanied by a comprehensive commercial supply agreement for seed treatment products between Corteva and Vylor, establishing long-term purchase obligations and exclusivity provisions.
Key Facts
- Corteva (RemainCo) completed the spin-off of its seed business into Vylor Inc. on October 1, 2026.
- Corteva (RemainCo) will retain the crop protection business.
- Vylor will be a separate publicly traded company.
- Corteva stockholders will receive one share of Vylor for each share of Corteva held.
- Corteva and Vylor entered into a Global Master Seed Treatment Framework Agreement for supply of seed treatment products.
- The supply agreement includes minimum purchase requirements and exclusivity provisions for Vylor for certain products.
- The separation agreement allocates 62% of shared liabilities to Vylor (SpinCo) and 38% to Corteva (RemainCo).
- The distribution date is October 1, 2026.
- The record date for the distribution was September 24, 2026.
Financial Impact
No financial figures for the spin-off or the value of the seed business or the supply agreement were disclosed in the filing.
Risk Factors
- Execution risk in the seed business as a standalone entity and the impact of the separation on Corteva's remaining crop protection business.
- Execution of the supply agreement and potential for supply disruptions or cost overruns.
- Potential for competitive dynamics in the seed treatment market.
- Potential for regulatory changes impacting the seed treatment products.
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-414490 |
| Document: ck0001755672-ex10_5.htm | 0001193125-26-414490 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | Press Release | $12.45 | awaiting T+5 | — | $11.95 (−4.02%) |
Oct 13, 2026 13d ago | 8-K | $13.36 $12.90 | ▲ +3.44% | ▲ +2.29% | $11.95 (+10.55%) |
Oct 5, 2026 21d ago | 3 | $13.91 $13.36 | ▼ −3.95% | ▼ −3.82% | $11.95 (−14.09%) |
Oct 5, 2026 21d ago | 8-K | $13.91 $13.36 | ▼ −3.95% | ▼ −3.82% | $11.95 (−14.09%) |
Oct 1, 2026 25d ago | 8-K | $12.57 $13.75 | ▲ +9.39% | ▲ +8.09% | $11.95 (−4.93%) |
Oct 1, 2026 25d ago | 8-K | $12.57 $13.75 | ▲ +9.39% | ▲ +8.09% | $11.95 (−4.93%) |
Sep 30, 2026 26d ago | 8-K | $12.57 $13.75 | ▲ +9.39% | ▲ +8.09% | $11.95 (−4.93%) |
Sep 30, 2026 26d ago | 8-K | $11.65 $14.45 | ▲ +24.03% | ▲ +22.12% | $11.95 (+2.57%) |
Sep 25, 2026 4w ago | 8-K | $78.52 $79.45 | ▲ +1.18% | ▲ +1.40% | $11.95 (−84.78%) |
Sep 24, 2026 4w ago | 8-K | $78.52 $79.45 | ▲ +1.18% | ▲ +1.40% | $11.95 (−84.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers